NNOX
Nano-X Imaging Ltd
$
4.550
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.6051
Open
4.490
VWAP
4.47
Vol
1.75M
Mkt Cap
290.93M
Low
4.340
Amount
7.83M
EV/EBITDA(TTM)
--
Total Shares
57.79M
EV
224.92M
EV/OCF(TTM)
--
P/S(TTM)
23.22
Nano-X Imaging Ltd is an Israel-based company that develops a digital X-ray source enabling a cost reduction of imaging systems.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
4.87M
+72.82%
--
--
3.94M
+31.24%
--
--
3.52M
+16.01%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Nano-X Imaging Ltd. (NNOX) for FY2025, with the revenue forecasts being adjusted by -7.51% over the past three months. During the same period, the stock price has changed by -20.32%.
Revenue Estimates for FY2025
Revise Downward
-7.51%
In Past 3 Month
Stock Price
Go Down
-20.32%
In Past 3 Month
3 Analyst Rating
83.08% Upside
Wall Street analysts forecast NNOX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NNOX is 8.33 USD with a low forecast of 7.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
0 Hold
0 Sell
Strong Buy
83.08% Upside
Current: 4.550
Low
7.00
Averages
8.33
High
10.00
83.08% Upside
Current: 4.550
Low
7.00
Averages
8.33
High
10.00
Alliance Global Partners
Buy
downgrade
$9 -> $7
2025-05-22
Reason
Alliance Global Partners
Price Target
$9 -> $7
2025-05-22
downgrade
Buy
Reason
Alliance Global Partners lowered the firm's price target on Nano-X Imaging to $7 from $9 and keeps a Buy rating on the shares. The firm cites the company's Q1 revenue missing forecasts, suggesting a challenging macro environment, the analyst tells investors in a research note.
D. Boral Capital
Jason Kolbert
Strong Buy
Maintains
$15
2025-04-17
Reason
D. Boral Capital
Jason Kolbert
Price Target
$15
2025-04-17
Maintains
Strong Buy
Reason
Cantor Fitzgerald
Ross Osborn
Buy
Maintains
$12 → $9
2025-04-01
Reason
Cantor Fitzgerald
Ross Osborn
Price Target
$12 → $9
2025-04-01
Maintains
Buy
Reason
Meeting to be held in New York on April 1 hosted by Cantor Fitzgerald.
D. Boral Capital
Jason Kolbert
Strong Buy
Maintains
$15
2025-03-31
Reason
D. Boral Capital
Jason Kolbert
Price Target
$15
2025-03-31
Maintains
Strong Buy
Reason
D. Boral Capital lowered the firm's price target on Nano-X Imaging to $15 from $23 and keeps a Buy rating on the shares following the Q4 report. The firm reduced its market penetration assumptions for the next few years given the time required for market build-out. Nano-X is strengthening its commercial outlook, but broader adoption will depend on clinical validation, market penetration strategies, and regulatory approvals across various regions, the analyst tells investors in a research note.
D. Boral Capital
Jason Kolbert
Strong Buy
Initiates
$23
2025-01-06
Reason
D. Boral Capital
Jason Kolbert
Price Target
$23
2025-01-06
Initiates
Strong Buy
Reason
Unusual total active option classes on open include: Cerence (CRNC), Emerson (EMR), Gevo (GEVO), Carvana (CVNA), Nano X (NNOX), Vistra Energy (VST), First Solar (FSLR), JD.com (JD), US Steel (X), and Mobileye (MBLY).
Cantor Fitzgerald
Ross Osborn
Buy
Maintains
$11 → $12
2024-12-06
Reason
Cantor Fitzgerald
Ross Osborn
Price Target
$11 → $12
2024-12-06
Maintains
Buy
Reason
Cantor Fitzgerald lowered the firm's price target on Nano-X Imaging to $11 from $14 and keeps an Overweight rating on the shares following the Q3 results. Nano-X reported revenue of $3M, below consensus estimates, driven by the company's teleradiology services, which increased 18% year over year to $2.6M, while AI solutions increased 184% y/y to $0.4M, the analyst tells investors in a research note. U.S. deployments are ramping, and Cantor sees the potential for an expanded indication for general scans that would materially increase the company's market opportunity and a next-gen device in development.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Nano-X Imaging Ltd (NNOX.O) is -6.66, compared to its 5-year average forward P/E of -14.63. For a more detailed relative valuation and DCF analysis to assess Nano-X Imaging Ltd 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-14.63
Current PE
-6.66
Overvalued PE
-2.61
Undervalued PE
-26.65
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-6.34
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
8.75
Undervalued EV/EBITDA
-21.43
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
625.52
Current PS
0.00
Overvalued PS
2199.38
Undervalued PS
-948.33
Financials
Annual
Quarterly
FY2025Q1
YoY :
+10.26%
2.82M
Total Revenue
FY2025Q1
YoY :
+7.61%
-14.09M
Operating Profit
FY2025Q1
YoY :
+8.15%
-13.24M
Net Income after Tax
FY2025Q1
YoY :
-0.00%
-0.21
EPS - Diluted
FY2025Q1
YoY :
+13.23%
-10.85M
Free Cash Flow
FY2025Q1
YoY :
+34.63%
-108.31
Gross Profit Margin - %
FY2025Q1
YoY :
-22.56%
-351.95
FCF Margin - %
FY2025Q1
YoY :
-1.91%
-470.30
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
352.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NNOX News & Events
Events Timeline
2025-08-12 (ET)
2025-08-12
08:07:06
Nano-X Imaging reports Q2 EPS (17c) vs (14c) last year
2025-07-01 (ET)
2025-07-01
08:04:45
Nano-X Imaging announces clinical, educational collab with Keiser University
2025-06-05 (ET)
2025-06-05
08:05:17
Nano-X Imaging receives MDR CE mark for HealthOST
Sign Up For More Events
Sign Up For More Events
News
4.0
14:36 PMBenzingaD. Boral Capital Maintains Buy on Nano X Imaging, Lowers Price Target to $8
9.5
08-01NewsfilterNanox to Report Second Quarter 2025 Financial Results on August 12, 2025
9.0
06-05NewsfilterNanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment
Sign Up For More News
People Also Watch
GLRE
Greenlight Capital Re Ltd
13.260
USD
+0.91%
MGTX
MeiraGTx Holdings PLC
8.340
USD
+3.99%
RNAC
Cartesian Therapeutics Inc
11.710
USD
+3.35%
ALT
Altimmune Inc
3.740
USD
+3.31%
BCAL
California Bancorp
16.200
USD
+0.75%
GAIN
Gladstone Investment Corp
14.530
USD
+2.61%
RDVT
Red Violet Inc
43.990
USD
+3.05%
GHM
Graham Corp
51.890
USD
+3.39%
FAQ
What is Nano-X Imaging Ltd (NNOX) stock price today?
The current price of NNOX is 4.55 USD — it has increased 2.13 % in the last trading day.
What is Nano-X Imaging Ltd (NNOX)'s business?
What is the price predicton of NNOX Stock?
What is Nano-X Imaging Ltd (NNOX)'s revenue for the last quarter?
What is Nano-X Imaging Ltd (NNOX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Nano-X Imaging Ltd (NNOX)'s fundamentals?
How many employees does Nano-X Imaging Ltd (NNOX). have?